Compare Logitech International SA (LOGI) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Logitech International SA vs TG Therapeutics Inc — how do they compare? Logitech International SA trades at $98.27 (market cap $14.46B), while TG Therapeutics Inc trades at $55.37 (market cap $8.16B). The key difference: Logitech International SA is the larger of the two by market cap, and Logitech International SA pays a 1.63% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Logitech International SA for 92 Days and TG Therapeutics Inc for 16 Days on average.
| LOGI | TGTX | |
|---|---|---|
Market Cap | $14.46B | $8.16B |
Volume | 349,547 | 1,735,121 |
Sector | Technology | Health |
52-Week High | $126.69 | $59.06 |
52-Week Low | $85.84 | $26.94 |
Typical Hold Time | 92 Days | 16 Days |
Enterprise Value | $12.79B | $8.37B |
Dividend Yield | 1.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Logitech (LOGI) trades at $101.50, down 0.67% on the day, with neutral technical indicators and mixed analyst sentiment. The company demonstrates strong profitability with 45.13% gross margins and 35.29% ROE, while recent earnings beats and new product launches including Zone Vibe Pro headsets and gaming partnerships signal innovation momentum. Cash flow trends show operational strength despite recent net outflow.
Outlook remains balanced with 5.3% upside to consensus price target of $107, though analyst ratings are evenly split. Key risks include chip shortage challenges cited by management and competitive pressures in the peripheral market. Revenue growth acceleration to $4.9B projected for 2026 supports potential valuation expansion if execution continues.
TG Therapeutics (TGTX) trades at $53.34, up 0.74% today, but faces bearish technical signals despite strong profitability metrics like a 55.22% net income margin. Recent earnings misses and a shareholder investigation create headwinds, though revenue growth and a high analyst buy consensus of 84.62% suggest underlying strength. The stock's current price is near key support at $52, with resistance at $54.
The outlook is mixed: robust revenue growth and institutional buying support upside toward the $80.50 consensus target, but earnings misses and legal risks pose challenges. Investors should weigh the company's MS therapy momentum against execution and regulatory uncertainties for balanced risk-reward assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
